NLARx Newsletter Header
NLARx News
October 14, 2009
In This Issue
NLARx News
Featured Conferences
In the States
Outrage of the Week
Fraud & Abuse
Pharmaceuticals & Health Reform
Prices & Access
Conflicts of Interest
Patents & Generics
Advertising & Marketing
Pharma Watch
PBM Watch
Medicare & Medicaid
Reimportation
Electronic Records
Safety & Clinical Trials
Quick Links
Join Our Mailing List
NLARx News
NLARx, the Consumer Federation of America, and US PIRG Letter to Sen. Reid Supporting PBM Transparency More
Consumer Groups Urge Senate to Keep Pharmacy Benefit Manager Transparency in Health Care Reform More
Featured Conferences
Nov 6, 2009 NLARx Meeting in Boston, MA More
Lawyering for Access: Legal Strategies to Improve Access to Affordable Pharmaceuticals More
In the States
WEST VIRGINIA: AG Sues Large Pharmacies for Routinely Overcharging for Generics More
TEXAS: Caremark Sticking It to Texas Pharmacies More
WISCONSIN: Pharmacia Ordered to Pay $4.5 Million in Medicaid Fraud Case More
NEW HAMPSHIRE: Businesses and Doctors Back New Discount Drug Program More
Outrage of the Week
Hemophilia Patients Battle to Sue Firm that Sold Tainted Blood Products in Asia More
Fraud and Abuse
GAO: Medicaid Wastes Millions On Phony Prescriptions For Painkillers More
Medicaid Fraud More than $63 Million in 5 States Alone, GAO Report Finds More
Are Pharma Execs In Legal Jeopardy When their Firms Market Drugs for Unapproved Uses? More
Pharmaceuticals and Health Reform
PhRMA Statement on Senate Finance Committee Vote More
Lawmakers Get Contributions From Industry Groups And Associated Lobbyists More
Coburn Opposes Medicare Part B Premiums Freeze, McCain Calls Drug Pact 'Unsavory' More
Prices and Access to Health Care
What Health Care Reform? Drug Are Prices Rising More
Healthcare Reform Without Drug Price Controls? That's Sick More
Pfizer's Selzentry Poised To Be Most Expensive First-Line AIDS Drug More
Conflicts of Interest
New Pharma Guidelines: No Ghostwriting, More Public Info More
Shareholder "Taken Aback" by Physician Payments More
BU Hospital May Tighten Conflicts Policy More
Patents and Generics
Generics: A Prescription for Lower Costs More
US Congress Urged to Act on Biosimilars More
Consumer Groups Battle Eshoo's Health Care Amendment to Block Biogenerics More
EC Antitrust Probes Aren't Over, Official Says More
Sanofi to Launch Copycat Plavix More
Advertising and Marketing
Fearing FDA, Pharma Abandons Search Ads More
FDA Warnings Chilled Sponsored Link Ads More
FDA Seeks Comments Regarding the Online Marketing of Regulated Products More
Selling Sickness: How Drug Ads Changed Health Care More
As TV Drug Ads Increase, So Do Concerns More
Pharma Eyes Loyalty Cards for Compliance More
Doctor Arrested on Charges of Selling Herbs as Cancer Cure More
Franken Backs Repeal of DTC Tax Break More
AZ outlined 'weight-neutral' Seroquel pitch More
Some Information About Bayer, Selenium, and Cancer More
Pharma Watch
Econo-Gloom Bypasses Pharma Earnings More
IMS: Pharma Growing Faster Than Expected More
U.S. Drug Sales Projected to Rise 5% This Year More
Pharmaceuticals Growth to Cross $825 Billion in 2010 More
The Biotech-Pharma Partnership Recipe More
Google's Venture Capital Wing Invests In Biotech Company More
GSK's $3.2 Billion Bet on Pandemic Pays Off More
Pharma CEOs: Tax Soda, Cap Malpractice, Pay for Prevention More
Top 15 Women in Pharma More
PBM Watch
CVS Caremark Research Illustrates How Innovative Pharmacy Benefit Plan Design Optimizes Generic Utilization More
Consumer Groups Urge Senate to Keep Pharmacy Benefit Manager Transparency in Health Care Reform More
Tamiflu Compounding Issues Prove How Inflexible PBMs Are More
Express Scripts: Breacher Moves To Prove More Records Breached More
Medicare and Medicaid
Higher Medicare Part D Deductibles Next Year More
Updated Online 50-State Database Provides Comprehensive Source on Medicaid Benefits More
Medicare Part D Spotlight: Part D Plan Availability in 2010 and Key Changes Since 2006 More
Pharmacies Sue States They Say Underpaid Them For Prescription Drugs More
How Cutting Payments for a Drug Could Cost Medicare More More
States Speak Up: Medicaid Spending Among Top Issues More
States Face Rising Medicaid Rolls Under Health Reform More
Medicare Code Favors Costly Lucentis Use More
Rate of Enrollment in Medicaid Rose Rapidly, Report Says More
Reimportation and Trade
Dorgan Will Offer Amendment on Importing Prescription Drugs More
European Court Sides With Drug Companies Over Pricing Matter More
Court Tells E.U. to Rethink Pharma Trade More
Free Trade in Health Care: The Gains from Globalized Medicare and Medicaid More
Electronic Records
Doctors, Hospitals Lag On EMR But Use Props - New And Old - To Close Gap More
Incentives Move Doctors To E-Prescribe; Hospitals Slow To Join HIT Exchanges More
Safety and Clinical Trials
Glaxo Must Pay $2.5M Over Paxil & Birth Defects More
What Can We Expect from Obama's FDA? More
Bayer Sued Over Prostate Cancer Claim More
FDA: Reformulated Heparin Less Potent More
The HIV Vaccine and Science by Press Release More
France's Chirac Plots Anti-Counterfeiting Push More